8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Feb 20, 2026·SEC
Material company update
Feb 19, 2026·SEC
Balchem Corporation(BCPC)Earnings, Financials & Key Ratios
BCPC•NASDAQ
34.9× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustryIngredients, pigments and specialty minerals
AboutBalchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.Show more
- Revenue$1.04B+8.8%
- EBITDA$264M+14.1%
- Net Income$155M+20.5%
- EPS (Diluted)4.75+20.9%
- Gross Margin35.74%+1.4%
- EBITDA Margin25.41%+5.0%
- Operating Margin21.05%+9.8%
- Net Margin14.93%+10.8%
- ROE12.86%+10.3%
BCPC Key Insights
Balchem Corporation (BCPC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 9/9
- ✓FCF machine: 16.7% free cash flow margin
- ✓16 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy 5Y average net margin of 12.7%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when BCPC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BCPC Price & Volume
Balchem Corporation (BCPC) stock price & volume — 10-year historical chart
Loading chart...
BCPC Growth Metrics
Balchem Corporation (BCPC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.5%
5 Years8.07%
3 Years3.25%
TTM9.62%
Profit CAGR
10 Years10%
5 Years12.84%
3 Years13.69%
TTM15.77%
EPS CAGR
10 Years9.65%
5 Years12.81%
3 Years13.48%
TTM16.79%
Return on Capital
10 Years11.73%
5 Years12.37%
3 Years12.81%
Last Year14.81%
BCPC Recent Earnings
Balchem Corporation (BCPC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.25-12.6%
$1.43
Rev
$271M+1.6%
$267M
Q1 2026
Feb 20, 2026Metric
Actual
Est
EPS
$1.31+1.6%
$1.29
Rev
$264M+1.6%
$260M
Q4 2025
Oct 21, 2025Metric
Actual
Est
EPS
$1.35-0.7%
$1.36
Rev
$268M+3.1%
$260M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$1.27+1.6%
$1.25
Rev
$255M-0.8%
$258M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.25vs $1.43-12.6% | $271Mvs $267M+1.6% |
| Q1 2026 | Feb 20, 2026 | $1.31vs $1.29+1.6% | $264Mvs $260M+1.6% |
| Q4 2025 | Oct 21, 2025 | $1.35vs $1.36-0.7% | $268Mvs $260M+3.1% |
| Q3 2025 | Jul 31, 2025 | $1.27vs $1.25+1.6% | $255Mvs $258M-0.8% |
Based on last 12 quarters of dataView full earnings history →
BCPC Peer Comparison
Balchem Corporation (BCPC) competitors in Ingredients, pigments and specialty minerals — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 INGR | 6.17B | 97.93 | 8.76 | -2.84% | 10.1% | 17.14% | 0.41 | |
 IFF | 19.6B | 76.72 | -52.55 | -5.17% | 7.78% | 5.88% | 0.47 | |
 AVNT | 3.45B | 37.66 | 42.31 | 0.61% | 4.81% | 6.6% | 0.81 | |
 HWKN | 3.37B | 161.45 | 41.29 | 11.21% | 7.52% | 15.96% | 0.49 | |
 IOSP | 2.04B | 82.73 | 17.72 | -3.65% | 6.38% | 8.64% | 0.07 | |
 MGPI | 351.34M | 16.44 | -3.29 | -23.77% | -45.97% | -32.05% | 0.37 | |
 TRMK | 2.63B | 44.67 | 12.07 | 34.75% | 19.32% | 10.77% | 0.53 | |
 ADUS | 1.76B | 94.23 | 18.09 | 23.21% | 6.89% | 9.34% | 0.19 |
Compare BCPC vs Peers
Balchem Corporation (BCPC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BCPC Income Statement
Balchem Corporation (BCPC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 594.79M | 643.68M | 643.71M | 703.64M | 799.02M | 942.36M | 922.44M | 953.68M | 1.04B | 1.06B |
Revenue Growth % | 7.52% | 8.22% | 0% | 9.31% | 13.55% | 17.94% | -2.11% | 3.39% | 8.75% | 9.62% |
Cost of Goods Sold | 405.78M | 439.43M | 432.34M | 479.75M | 555.85M | 661.91M | 620.38M | 617.48M | 666.53M | 673.8M |
COGS % of Revenue | 68.22% | 68.27% | 67.16% | 68.18% | 69.57% | 70.24% | 67.25% | 64.75% | 64.26% | - |
Gross Profit | 189.01M▲ 0% | 204.25M▲ 8.1% | 211.37M▲ 3.5% | 223.9M▲ 5.9% | 243.17M▲ 8.6% | 280.45M▲ 15.3% | 302.06M▲ 7.7% | 336.21M▲ 11.3% | 370.63M▲ 10.2% | 383.55M▲ 0% |
Gross Margin % | 31.78% | 31.73% | 32.84% | 31.82% | 30.43% | 29.76% | 32.75% | 35.25% | 35.74% | 36.27% |
Gross Profit Growth % | 4.51% | 8.06% | 3.48% | 5.93% | 8.61% | 15.33% | 7.7% | 11.31% | 10.24% | - |
Operating Expenses | 91.75M | 96.5M | 108.81M | 112.75M | 115.67M | 135.26M | 142.86M | 153.3M | 152.3M | 161.83M |
OpEx % of Revenue | 15.43% | 14.99% | 16.9% | 16.02% | 14.48% | 14.35% | 15.49% | 16.07% | 14.68% | - |
Selling, General & Admin | 82.45M | 84.91M | 97.44M | 102.42M | 102.15M | 123.07M | 130.13M | 136.5M | 142.8M | 150.37M |
SG&A % of Revenue | 13.86% | 13.19% | 15.14% | 14.56% | 12.78% | 13.06% | 14.11% | 14.31% | 13.77% | - |
Research & Development | 9.3M | 11.59M | 11.38M | 10.33M | 13.52M | 12.19M | 15.05M | 16.79M | 18.51M | 24.92M |
R&D % of Revenue | 1.56% | 1.8% | 1.77% | 1.47% | 1.69% | 1.29% | 1.63% | 1.76% | 1.78% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -2.32M | 0 | -9.01M | -362K |
Operating Income | 96.9M▲ 0% | 107.1M▲ 10.5% | 102.55M▼ 4.2% | 111.15M▲ 8.4% | 127.5M▲ 14.7% | 145.19M▲ 13.9% | 159.19M▲ 9.6% | 182.91M▲ 14.9% | 218.33M▲ 19.4% | 221.72M▲ 0% |
Operating Margin % | 16.29% | 16.64% | 15.93% | 15.8% | 15.96% | 15.41% | 17.26% | 19.18% | 21.05% | 20.97% |
Operating Income Growth % | 6.68% | 10.52% | -4.25% | 8.38% | 14.71% | 13.87% | 9.65% | 14.9% | 19.37% | - |
EBITDA | 141.28M | 151.77M | 148.41M | 162.43M | 176.38M | 197.03M | 214.13M | 230.88M | 263.52M | 266.76M |
EBITDA Margin % | 23.75% | 23.58% | 23.06% | 23.08% | 22.07% | 20.91% | 23.21% | 24.21% | 25.41% | 25.23% |
EBITDA Growth % | 3.1% | 7.42% | -2.21% | 9.44% | 8.59% | 11.71% | 8.68% | 7.82% | 14.14% | 12.29% |
D&A (Non-Cash Add-back) | 44.38M | 44.67M | 45.86M | 51.28M | 48.88M | 51.85M | 54.94M | 47.97M | 45.19M | 45.04M |
EBIT | 96.02M | 106.64M | 102.44M | 110.86M | 127.69M | 144.02M | 159.87M | 182.98M | 209.25M | 158.38M |
Net Interest Income | -7.53M | -7.61M | -5.96M | -4.44M | -2.46M | -10.27M | -22.61M | -16.53M | -10.22M | -7.29M |
Interest Income | 12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 7.54M | 7.61M | 5.96M | 4.44M | 2.46M | 10.27M | 22.61M | 16.53M | 10.22M | 10.4M |
Other Income/Expense | -8.41M | -8.07M | -6.08M | -4.73M | -2.27M | -11.44M | -21.93M | -16.46M | -19.3M | -18.1M |
Pretax Income | 88.49M▲ 0% | 99.03M▲ 11.9% | 96.48M▼ 2.6% | 106.42M▲ 10.3% | 125.23M▲ 17.7% | 133.75M▲ 6.8% | 137.26M▲ 2.6% | 166.45M▲ 21.3% | 199.03M▲ 19.6% | 203.61M▲ 0% |
Pretax Margin % | 14.88% | 15.38% | 14.99% | 15.12% | 15.67% | 14.19% | 14.88% | 17.45% | 19.19% | 19.26% |
Income Tax | -1.58M | 20.46M | 16.81M | 21.79M | 29.13M | 28.38M | 28.72M | 37.98M | 44.19M | 45.53M |
Effective Tax Rate % | -1.79% | 20.66% | 17.42% | 20.48% | 23.26% | 21.22% | 20.92% | 22.82% | 22.2% | 22.36% |
Net Income | 90.07M▲ 0% | 78.57M▼ 12.8% | 79.67M▲ 1.4% | 84.62M▲ 6.2% | 96.1M▲ 13.6% | 105.37M▲ 9.6% | 108.54M▲ 3.0% | 128.47M▲ 18.4% | 154.84M▲ 20.5% | 158.08M▲ 0% |
Net Margin % | 15.14% | 12.21% | 12.38% | 12.03% | 12.03% | 11.18% | 11.77% | 13.47% | 14.93% | 14.95% |
Net Income Growth % | 60.92% | -12.77% | 1.4% | 6.22% | 13.57% | 9.64% | 3.01% | 18.36% | 20.53% | 15.77% |
Net Income (Continuing) | 90.07M | 78.57M | 79.67M | 84.62M | 96.1M | 105.37M | 108.54M | 128.47M | 154.84M | 158.08M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 2.79▲ 0% | 2.42▼ 13.3% | 2.45▲ 1.2% | 2.60▲ 6.1% | 2.94▲ 13.1% | 3.25▲ 10.5% | 3.35▲ 3.1% | 3.93▲ 17.3% | 4.75▲ 20.9% | 4.90▲ 0% |
EPS Growth % | 59.43% | -13.26% | 1.24% | 6.12% | 13.08% | 10.54% | 3.08% | 17.31% | 20.87% | 16.79% |
EPS (Basic) | 2.81 | 2.44 | 2.48 | 2.63 | 2.98 | 3.29 | 3.38 | 3.97 | 4.80 | - |
Diluted Shares Outstanding | 32.23M | 32.45M | 32.51M | 32.5M | 32.67M | 32.39M | 32.45M | 32.72M | 32.6M | 32.28M |
Basic Shares Outstanding | 32.02M | 32.26M | 32.14M | 32.18M | 32.22M | 32.02M | 32.11M | 32.33M | 32.6M | 32.28M |
Dividend Payout Ratio | 13.4% | 17.09% | 19% | 19.74% | 19.48% | 19.66% | 21.07% | 19.91% | 18.27% | - |
BCPC Balance Sheet
Balchem Corporation (BCPC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 199.34M | 226.31M | 254.95M | 266.89M | 322.23M | 335.8M | 314.24M | 313.77M | 365.61M | 388.94M |
Cash & Short-Term Investments | 40.42M | 54.27M | 65.67M | 84.57M | 103.24M | 66.56M | 64.45M | 49.52M | 74.57M | 72.87M |
Cash Only | 40.42M | 54.27M | 65.67M | 84.57M | 103.24M | 66.56M | 64.45M | 49.52M | 74.57M | 72.87M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 91.23M | 99.55M | 93.44M | 98.21M | 117.41M | 131.58M | 125.28M | 119.66M | 143.6M | 154.23M |
Days Sales Outstanding | 55.98 | 56.45 | 52.99 | 50.95 | 53.63 | 50.96 | 49.57 | 45.8 | 50.53 | 48.79 |
Inventory | 60.7M | 67.19M | 83.89M | 70.62M | 91.06M | 119.67M | 109.52M | 130.8M | 131.45M | 146.74M |
Days Inventory Outstanding | 54.6 | 55.81 | 70.83 | 53.73 | 59.79 | 65.99 | 64.44 | 77.32 | 71.98 | 75.67 |
Other Current Assets | 2.22M | 1.48M | 7.55M | 3.44M | 4.41M | 13.09M | 7.19M | 5.74M | 16M | 15.09M |
Total Non-Current Assets | 764.3M | 755.04M | 900.74M | 898.96M | 877.09M | 1.29B | 1.28B | 1.26B | 1.34B | 1.3B |
Property, Plant & Equipment | 189.79M | 194.34M | 224.2M | 236.51M | 246.81M | 290.79M | 295.9M | 299.2M | 322.84M | 318.2M |
Fixed Asset Turnover | 3.13x | 3.31x | 2.87x | 2.98x | 3.24x | 3.24x | 3.12x | 3.19x | 3.21x | 3.35x |
Goodwill | 441.36M | 448M | 524M | 529.46M | 523.95M | 769.51M | 778.91M | 780.03M | 816.38M | 811.45M |
Intangible Assets | 128.07M | 105.98M | 143.92M | 121.66M | 94.67M | 213.29M | 191.21M | 165.05M | 163.29M | 156.46M |
Long-Term Investments | 4.8M | 4.9M | -56.43M | -51.36M | -46.45M | 4.29M | 4.08M | 3.86M | 3.72M | 7.43M |
Other Non-Current Assets | -48.28M | -42.49M | 8.62M | 11.33M | 11.67M | -51.96M | 12.87M | 13.46M | 14.42M | 18.69M |
Total Assets | 963.64M▲ 0% | 981.36M▲ 1.8% | 1.16B▲ 17.8% | 1.17B▲ 0.9% | 1.2B▲ 2.9% | 1.62B▲ 35.5% | 1.6B▼ 1.7% | 1.58B▼ 1.4% | 1.71B▲ 8.4% | 1.69B▲ 0% |
Asset Turnover | 0.62x | 0.66x | 0.56x | 0.60x | 0.67x | 0.58x | 0.58x | 0.61x | 0.61x | 0.63x |
Asset Growth % | 1.58% | 1.84% | 17.76% | 0.88% | 2.87% | 35.45% | -1.68% | -1.37% | 8.39% | 23.67% |
Total Current Liabilities | 108.4M | 82.06M | 92.26M | 94.43M | 143.8M | 140.04M | 148.49M | 157.69M | 176.38M | 152.54M |
Accounts Payable | 28.45M | 33.79M | 37.27M | 23.74M | 56.24M | 57.32M | 55.5M | 54.74M | 60.42M | 0 |
Days Payables Outstanding | 25.59 | 28.07 | 31.46 | 18.06 | 36.93 | 31.61 | 32.66 | 32.36 | 33.09 | 23.74 |
Short-Term Debt | 35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.82M | 33.71M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 13.85M | 2.26M | 41.46M | 48.6M | 65.63M | 62.15M | 71.54M | 22.89M | 77.18M | 118.83M |
Current Ratio | 1.84x | 2.76x | 2.76x | 2.83x | 2.24x | 2.40x | 2.12x | 1.99x | 2.07x | 2.55x |
Quick Ratio | 1.28x | 1.94x | 1.85x | 2.08x | 1.61x | 1.54x | 1.38x | 1.16x | 1.33x | 1.59x |
Cash Conversion Cycle | 84.99 | 84.19 | 92.35 | 86.61 | 76.49 | 85.34 | 81.35 | 90.76 | 89.43 | 100.73 |
Total Non-Current Liabilities | 238.36M | 207.68M | 319.76M | 243.18M | 178.51M | 546.19M | 394.74M | 267.77M | 273.76M | 256.09M |
Long-Term Debt | 183.96M | 156M | 248.57M | 163.57M | 108.57M | 440.57M | 309.57M | 190M | 175.32M | 33.71M |
Capital Lease Obligations | 0 | 0 | 4.83M | 6.08M | 7.11M | 16.02M | 16.54M | 14.72M | 12.87M | 40.53M |
Deferred Tax Liabilities | 48.55M | 44.31M | 56.43M | 51.36M | 46.45M | 62.78M | 52.05M | 43.72M | 75.45M | 224.2M |
Other Non-Current Liabilities | 5.85M | 7.37M | 9.93M | 22.18M | 16.37M | 26.81M | 16.58M | 19.34M | 10.12M | 169M |
Total Liabilities | 346.75M | 289.74M | 412.01M | 337.61M | 322.31M | 686.23M | 543.23M | 425.46M | 450.15M | 408.63M |
Total Debt | 218.96M | 156M | 255.87M | 171.99M | 118.04M | 460.61M | 330.33M | 208.04M | 192.01M | 33.71M |
Net Debt | 178.55M | 101.73M | 190.2M | 87.41M | 14.8M | 394.05M | 265.89M | 158.53M | 117.44M | -39.16M |
Debt / Equity | 0.35x | 0.23x | 0.34x | 0.21x | 0.13x | 0.49x | 0.31x | 0.18x | 0.15x | 0.03x |
Debt / EBITDA | 1.55x | 1.03x | 1.72x | 1.06x | 0.67x | 2.34x | 1.54x | 0.90x | 0.73x | 0.13x |
Net Debt / EBITDA | 1.26x | 0.67x | 1.28x | 0.54x | 0.08x | 2.00x | 1.24x | 0.69x | 0.45x | -0.15x |
Interest Coverage | 12.73x | 14.01x | 17.19x | 24.97x | 51.99x | 14.03x | 7.07x | 11.07x | 20.48x | 15.23x |
Total Equity | 616.88M▲ 0% | 691.62M▲ 12.1% | 743.67M▲ 7.5% | 828.23M▲ 11.4% | 877.01M▲ 5.9% | 938.28M▲ 7.0% | 1.05B▲ 12.3% | 1.15B▲ 9.1% | 1.26B▲ 9.3% | 1.29B▲ 0% |
Equity Growth % | 18.4% | 12.12% | 7.53% | 11.37% | 5.89% | 6.99% | 12.33% | 9.1% | 9.35% | 39.9% |
Book Value per Share | 19.14 | 21.32 | 22.88 | 25.48 | 26.84 | 28.97 | 32.48 | 35.15 | 38.57 | 39.81 |
Total Shareholders' Equity | 616.88M | 691.62M | 743.67M | 828.23M | 877.01M | 938.28M | 1.05B | 1.15B | 1.26B | 1.29B |
Common Stock | 2.13M | 2.15M | 2.16M | 2.16M | 2.15M | 2.15M | 2.15M | 2.17M | 2.14M | 2.14M |
Retained Earnings | 464.64M | 528.03M | 590.92M | 656.74M | 732.14M | 814.49M | 897.49M | 997.49M | 1.12B | 1.16B |
Treasury Stock | 0 | -56K | -18.07M | -7.87M | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -1.64M | -3.6M | -5.56M | 4.17M | -4.99M | -7.15M | 8.69M | -23.75M | 41.55M | 31.75M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BCPC Cash Flow Statement
Balchem Corporation (BCPC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 110.62M | 118.7M | 124.46M | 150.49M | 160.51M | 138.54M | 183.76M | 182M | 216.56M | 220.16M |
Operating CF Margin % | 18.6% | 18.44% | 19.34% | 21.39% | 20.09% | 14.7% | 19.92% | 19.08% | 20.88% | - |
Operating CF Growth % | 2.79% | 7.3% | 4.86% | 20.92% | 6.66% | -13.69% | 32.64% | -0.96% | 18.99% | 71.32% |
Net Income | 90.07M | 78.57M | 79.67M | 84.62M | 96.1M | 105.37M | 108.54M | 128.47M | 154.84M | 158.08M |
Depreciation & Amortization | 44.38M | 44.67M | 45.86M | 51.28M | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M | 47.17M |
Stock-Based Compensation | 6.26M | 6.41M | 7.6M | 8.3M | 10.8M | 13.22M | 16.05M | 16.68M | 18.06M | 19.6M |
Deferred Taxes | -28.78M | -5.4M | -3.56M | -4.63M | -5.94M | -8.36M | -10.81M | -6.78M | 6.26M | 115K |
Other Non-Cash Items | 663K | -1.54M | -146K | 2.38M | -257K | 1.68M | -4.96M | 1.77M | -835K | -20.12M |
Working Capital Changes | -1.98M | -4.01M | -4.96M | 8.53M | 10.93M | -25.22M | 20.01M | -6.12M | -7.46M | 15.31M |
Change in Receivables | -3.91M | -7.77M | 11.62M | -3.6M | -20.7M | -3.62M | 6.97M | 5.58M | -20.85M | 10.07M |
Change in Inventory | -319K | -6.02M | -11.4M | 13.92M | -21.02M | -7.8M | 10.53M | -22.79M | 3.63M | 12.9M |
Change in Payables | 1.51M | 5.99M | 1.13M | -3.85M | 46.19M | -15.54M | 3.55M | 9.06M | 11.29M | 737K |
Cash from Investing | -42.7M | -31.99M | -156.22M | -34.59M | -35.3M | -416.01M | -34.81M | -59.74M | -43.89M | -44.27M |
Capital Expenditures | -28.09M | -19.72M | -28.41M | -33.83M | -37.45M | -50.29M | -37.89M | -35.66M | -43.49M | 5.56M |
CapEx % of Revenue | 4.72% | 3.06% | 4.41% | 4.81% | 4.69% | 5.34% | 4.11% | 3.74% | 4.19% | 0.53% |
Acquisitions | -17.39M | -17.4M | -141.06M | 87K | 318K | -365.78M | -1.54M | -24.16M | -49K | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 2.79M | 5.13M | 13.25M | -850K | 1.83M | 56K | 1.88M | 89K | 0 | -49.86M |
Cash from Financing | -68.63M | -71.45M | 43.38M | -101.16M | -102.18M | 246.68M | -153.32M | -133.81M | -152.81M | -155.62M |
Debt Issued (Net) | -64.38M | -63.52M | 75M | -85.15M | -55.16M | 300.83M | -131.22M | -119.78M | -26.19M | 1K |
Equity Issued (Net) | -1.91M | -1.39M | -21.32M | -13.46M | -35.24M | -35.42M | -4.47M | -5.68M | -98.33M | -102.31M |
Dividends Paid | -12.07M | -13.43M | -15.13M | -16.7M | -18.72M | -20.71M | -22.87M | -25.58M | -28.29M | -30.79M |
Share Repurchases | -1.91M | -1.39M | -21.32M | -13.46M | -35.24M | -35.42M | -4.47M | -5.68M | -107.64M | -118M |
Other Financing | 9.73M | 6.9M | 4.84M | 14.15M | 6.94M | 1.98M | 5.24M | 17.23M | 0 | -22.57M |
Net Change in Cash | 1.77M▲ 0% | 13.85M▲ 681.3% | 11.4M▼ 17.7% | 18.9M▲ 65.7% | 18.67M▼ 1.2% | -36.68M▼ 296.5% | -2.11M▲ 94.2% | -14.93M▼ 606.7% | 25.05M▲ 267.8% | 22.97M▲ 0% |
Free Cash Flow | 82.52M▲ 0% | 98.97M▲ 19.9% | 96.05M▼ 3.0% | 116.67M▲ 21.5% | 123.06M▲ 5.5% | 88.25M▼ 28.3% | 145.87M▲ 65.3% | 146.34M▲ 0.3% | 173.07M▲ 18.3% | 182.23M▲ 0% |
FCF Margin % | 13.87% | 15.38% | 14.92% | 16.58% | 15.4% | 9.36% | 15.81% | 15.34% | 16.69% | 17.23% |
FCF Growth % | -1.31% | 19.93% | -2.96% | 21.47% | 5.48% | -28.29% | 65.3% | 0.32% | 18.27% | 20.88% |
FCF per Share | 2.56 | 3.05 | 2.95 | 3.59 | 3.77 | 2.72 | 4.50 | 4.47 | 5.31 | 5.64 |
FCF Conversion (FCF/Net Income) | 1.23x | 1.51x | 1.56x | 1.78x | 1.67x | 1.31x | 1.69x | 1.42x | 1.40x | 1.15x |
Interest Paid | 7.02M | 6.94M | 0 | 4.67M | 4.55M | 11.88M | 25.93M | 17.7M | 10.6M | 7.59M |
Taxes Paid | 25.84M | 20.59M | 0 | 22.64M | 25.36M | 33.02M | 35.73M | 42.64M | 37.75M | 36.31M |
BCPC Key Ratios
Balchem Corporation (BCPC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 15.83% | 12.01% | 11.1% | 10.77% | 11.27% | 11.61% | 10.9% | 11.66% | 12.86% | 12.38% |
Return on Invested Capital (ROIC) | 9.33% | 10.11% | 8.91% | 9.01% | 10.58% | 9.79% | 9% | 10.44% | 12.21% | 12.24% |
Gross Margin | 31.78% | 31.73% | 32.84% | 31.82% | 30.43% | 29.76% | 32.75% | 35.25% | 35.74% | 36.27% |
Net Margin | 15.14% | 12.21% | 12.38% | 12.03% | 12.03% | 11.18% | 11.77% | 13.47% | 14.93% | 14.95% |
Debt / Equity | 0.35x | 0.23x | 0.34x | 0.21x | 0.13x | 0.49x | 0.31x | 0.18x | 0.15x | 0.03x |
Interest Coverage | 12.73x | 14.01x | 17.19x | 24.97x | 51.99x | 14.03x | 7.07x | 11.07x | 20.48x | 15.23x |
FCF Conversion | 1.23x | 1.51x | 1.56x | 1.78x | 1.67x | 1.31x | 1.69x | 1.42x | 1.40x | 1.15x |
Revenue Growth | 7.52% | 8.22% | 0% | 9.31% | 13.55% | 17.94% | -2.11% | 3.39% | 8.75% | 9.62% |
Related:BCPC Dividend History·BCPC Revenue History·BCPC Price History·BCPC P/E History·BCPC Financial Ratios·BCPC Institutional Holders
BCPC SEC Filings & Documents
Balchem Corporation (BCPC) SEC filings — annual & quarterly reports (10-K, 10-Q)
BCPC Frequently Asked Questions
Balchem Corporation (BCPC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Balchem Corporation (BCPC) reported $1.06B in revenue for fiscal year 2025. This represents a 3905% increase from $26.4M in 1996.
Balchem Corporation (BCPC) grew revenue by 8.8% over the past year. This is steady growth.
Yes, Balchem Corporation (BCPC) is profitable, generating $158.1M in net income for fiscal year 2025 (14.9% net margin).
Dividend & Returns
Yes, Balchem Corporation (BCPC) pays a dividend with a yield of 0.52%. This makes it attractive for income-focused investors.
Balchem Corporation (BCPC) has a return on equity (ROE) of 12.9%. This is reasonable for most industries.
Balchem Corporation (BCPC) generated $182.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.